Hormonal
Morbidly obese women exhibit significantly lower striatal dopamine D2/3 receptor availability compared to non-obese controls, suggesting a hypodopaminergic state that may drive compulsive eating.
This research suggests that obesity in some individuals may be linked to a biological difference in brain reward systems (specifically lower dopamine receptors), which can make food feel less rewarding and drive compulsive eating. This is not a moral failing but a neurochemical factor. While this doesn't provide a direct 'fix,' it highlights why standard willpower-based approaches might fail for some and suggests that treatments addressing brain reward pathways could be beneficial.
Striatal D2/3R availability was 23% (p=0.028) lower in obese compared with non-obese women.
Why this rating
Replication study with matched controls and rigorous SPECT imaging, though limited by small sample size (n=15 per group) and lack of causal proof.
Source
Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects
Barbara A. de Weijer et al. · EJNMMI Research · 2011
DOI 10.1186/2191-219x-1-37
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →